Tacrolimus Impurity 12 | CAS 160892-64-8 - Request Quote
Tacrolimus Impurity 12
| SZ CAT No: | SZ-T005050 |
| CAS No | 160892-64-8 |
| Mol.F. | C43H67NO14 |
| Mol.Wt. | 822.0 |
| Inv. Status | Synthesis on demand |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tacrolimus Impurity 12 is chemically . Tacrolimus Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Tacrolimus Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tacrolimus.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 160892-64-8
Purchase 160892-64-8
Order 160892-64-8
Enquire 160892-64-8
price of 160892-64-8
160892-64-8 Supplier
160892-64-8 Manufacturer
160892-64-8 Exporter
buy high quality Tacrolimus Impurity 12
Purchase Tacrolimus Impurity 12
Tacrolimus Impurity 12 suppliers
Tacrolimus Impurity 12 manufacturers
Tacrolimus Impurity 12 price
Order Tacrolimus Impurity 12
Enquire Tacrolimus Impurity 12
Tacrolimus Impurity 12 cost
Tacrolimus Impurity 12 Supplier
Tacrolimus Impurity 12 Distributor
Tacrolimus Impurity 12 for Method Validation
Tacrolimus Reference Standard
Tacrolimus Impurity 12 for ANDA Filing
Tacrolimus Impurity 12 for Forced Degradation Studies
Tacrolimus Impurity 12 Identification Standards
Tacrolimus Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


